Suppr超能文献

通过与基于壳聚糖的阳离子聚电解质结合改善源自[具体来源未给出]的L-天冬酰胺酶的生物催化特性和细胞毒性活性。

Improvement of Biocatalytic Properties and Cytotoxic Activity of L-Asparaginase from by Conjugation with Chitosan-Based Cationic Polyelectrolytes.

作者信息

Dobryakova Natalia V, Zhdanov Dmitry D, Sokolov Nikolay N, Aleksandrova Svetlana S, Pokrovskaya Marina V, Kudryashova Elena V

机构信息

Chemical Faculty, Lomonosov Moscow State University, Leninskie Gory St. 1, 119991 Moscow, Russia.

Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia.

出版信息

Pharmaceuticals (Basel). 2022 Mar 27;15(4):406. doi: 10.3390/ph15040406.

Abstract

L-asparaginases (L-ASNases, EC 3.5.1.1) are a family of enzymes that are widely used for the treatment of lymphoblastic leukemias. L-ASNase from (RrA) has a low molecular weight, low glutaminase activity, and low immunogenicity, making it a promising enzyme for antitumor drug development. In our work, the complex formation and covalent conjugation of the enzyme with synthetic or natural polycationic polymers was studied. Among non-covalent polyelectrolyte complexes (PEC), polyethyleneimine (PEI) yielded the highest effect on RrA, increasing its activity by 30%. The RrA-PEI complex had increased stability to trypsinolysis, with an inactivation constant decrease up to 10-fold compared to that of the native enzyme. The covalent conjugation of RrA with chitosan-PEI, chitosan-polyethylene glycol (chitosan-PEG), and chitosan-glycol resulted in an increase in the specific activity of L-asparagine (up to 30%). RrA-chitosan-PEG demonstrated dramatically (by 60%) increased cytotoxic activity for human chronic myeloma leukemia K562 cells in comparison to the native enzyme. The antiproliferative activity of RrA and its conjugates was significantly higher (up to 50%) than for that of the commercially available EcA at the same concentration. The results of this study demonstrated that RrA conjugates with polycations can become a promising strategy for antitumor drug development.

摘要

L-天冬酰胺酶(L-ASNases,EC 3.5.1.1)是一类广泛用于治疗淋巴细胞白血病的酶。来自[具体来源未提及](RrA)的L-天冬酰胺酶分子量低、谷氨酰胺酶活性低且免疫原性低,这使其成为抗肿瘤药物开发中一种有前景的酶。在我们的工作中,研究了该酶与合成或天然聚阳离子聚合物的复合物形成及共价偶联。在非共价聚电解质复合物(PEC)中,聚乙烯亚胺(PEI)对RrA的作用效果最佳,使其活性提高了30%。RrA-PEI复合物对胰蛋白酶消化的稳定性增强,与天然酶相比,失活常数降低了高达10倍。RrA与壳聚糖-PEI、壳聚糖-聚乙二醇(壳聚糖-PEG)以及壳聚糖-二醇的共价偶联导致L-天冬酰胺的比活性增加(高达30%)。与天然酶相比,RrA-壳聚糖-PEG对人慢性髓性白血病K562细胞的细胞毒性活性显著提高(60%)。在相同浓度下,RrA及其偶联物的抗增殖活性明显高于市售的EcA(高达50%)。本研究结果表明,RrA与聚阳离子的偶联物可能成为抗肿瘤药物开发的一种有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0126/9029710/70d9a46240e0/pharmaceuticals-15-00406-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验